MissionIR Articles

Celator Pharmaceuticals, Inc. (NASDAQ: CPXX) is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer. Celator’s proprietary technology platform, CombiPlex, enables the rational…

Intec Pharma Ltd. (NASDAQ: NTEC) is developing drugs based on its proprietary Accordion Pill platform technology. Accordion Pill is an oral drug delivery system designed to improve the efficacy and safety of existing drugs and…

Amedica Corp. (NASDAQ: AMDA) develops Silicon Nitride orthopedic and spinal implants. It is the only company that has FDA approval to produce and distribute medical grade Silicon Nitride. Amedica’s line of Silicone Nitride Interbody Fusion…

Axsome Therapeutics, Inc. (Nasdaq: AXSM) is a clinical stage biopharmaceutical company developing novel therapies for the management of pain and other central nervous system, or CNS, disorders. By focusing on this therapeutic area, the company…

Resverlogix Corp. (OTC: RVXCF) is an epigenetics company, creating small molecule therapeutics for BET inhibition. The company is currently developing apabetalone (RVX-208), a first-in-class, small molecule selective BET bromodomain inhibitor. It is the only selective…

Bionomics Ltd. (OTC: BNOEF) is a fully integrated, international drug discovery and development company creating new therapies that serve large unmet needs in cancer and central nervous system disorders such as depression, anxiety and Alzheimer’s.…

CorMedix, Inc. (NYSE: CRMD) is a commercial-stage pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. The company’s first commercial product in…

Enumeral Biomedical Holdings, Inc. (ENUM) is a biopharmaceutical company discovering and developing novel antibody immunotherapies that help the immune system fight cancer and other diseases. The company is building a pipeline focused on next-generation checkpoint…

Celsion Corp. (NASDAQ: CLSN), a fully-integrated oncology company, is focused on developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies. The company’s lead program is ThermoDox, a proprietary heat-activated…

NanoViricides, Inc. (NYSE: NNVC) is a nano-biopharmaceutical company focused on discovering, developing, and marketing therapeutics for the treatment of viral infections. The company is developing anti-flu drug candidates at pre-clinical and advanced pre-clinical stage.  These…

Cellectar Biosciences, Inc. (NASDAQ: CLRB) is developing agents to detect, treat and monitor a broad spectrum of cancers. With the ability to attach imaging and therapeutic agents to its proprietary delivery platform – a novel…

Protea Biosciences Group, Inc. (OTC: PRGB) is a provider of innovative bioanalytical solutions to the pharmaceutical and life science industries. The company applies its proprietary technology to identify and characterize the proteins, metabolites, lipids and…

Matinas BioPharma Holdings, Inc. (OTC: MTNB) is a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections. The company’s lead anti-infective…

Neuralstem, Inc.’s (NASDAQ: CUR) patented technology enables the commercial-scale production of multiple types of central nervous system (CNS) stem cells, which are being developed as potential therapies for many CNS diseases and conditions. The company…

Citius Pharmaceuticals, Inc. (OTC: CTXR) is a pharmaceutical company developing and commercializing therapeutic products for large and growing markets. Citius uses approved drugs with substantial safety and efficacy data in an effort to reduce the…

Cytori Therapeutics, Inc. (NASDAQ: CYTX) is committed to providing patients and physicians around the world with medical technologies, which harness the potential of adult stem and regenerative cells from adipose tissue. The proprietary Cytori Cell…

Antisense Therapeutics Ltd. (OTC: ATHJF) is an Australian pharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics. One of Antisense Therapeutics’ fundamental strategies is acquiring access to…

ContraVir Pharmaceuticals (NASDAQ: CTRV) is developing targeted antiviral therapies with two drug candidates in clinical studies. The first drug candidate, FV-100, is now in phase 3 trials. It is being developed for the treatment of…

Aytu BioScience, Inc. (OTC: AYTU) is a specialty healthcare company focused on developing and commercializing novel products in the field of urology. Aytu is initially concentrating on prostate cancer, male sexual dysfunction and male infertility…